腹部外科手术和肥胖相关的并发症的事件发展
Amanda L Bader1, Jesse Y Hsu2,3, Maria S Altieri1,3
1Department of Surgery, University of Pennsylvania Health System, Philadelphia.
JAMA network open
|September 9, 2025
概括
与单独的体重管理计划相比,减肥手术显著降低了发展主要代谢疾病的风险,如2型糖尿病和高血压. 这突出了外科手术的重点.
科学领域:
- 代谢健康 代谢健康
- 手术干预 手术干预
- 公共卫生 公共卫生
背景情况:
- 美国肥胖率的上升需要有效管理相关的代谢并发症.
- 腹部外科手术对减轻代谢条件有希望,但手术后的大规模风险数据有限.
研究的目的:
- 为了确定适合减肥手术的患者的代谢表型.
- 为了比较减肥手术后新代谢并发症的发病率与体重管理计划 (WMP).
主要方法:
- 使用退伍军人卫生管理局数据 (2008-2023) 进行回顾性多中心队列研究.
- 包括BMI≥30和≥1并发症的成年人,或BMI≥35,接受减肥手术或WMP (MOVE! ) 的情况.
- 排除标准:在基线时所有5种并发症或缺少关键数据.
主要成果:
- 与WMP相比,减肥手术与患2型糖尿病 (79.2%较低),高血压 (58.8%较低),高脂血症 (50.5%较低),阻断性睡眠呼吸暂停 (56.9%较低) 和与代谢功能障碍相关的脂肪性肝病 (40.4%较低) 的风险明显较低.
- 在5年内,每1000人/年的发病率显示,在减肥手术组中,所有研究的并发病的风险较低.
- 在对女性退伍军人的小组分析中,这些发现一致.
结论:
- 与非手术体重管理相比,腹部外科手术显示主要代谢并发症的风险显著降低.
- 这些发现支持减肥手术作为减轻肥胖相关健康风险的持久和有效策略.
- 这项研究强调了考虑减肥手术对于符合条件的个体的长期代谢健康管理的重要性.
相关概念视频
01:25Pharmacokinetics in Obese Patients: Drug Absorption and Distribution
211
Obesity significantly alters the pharmacokinetic processes of drug absorption and distribution, presenting unique challenges in medical treatment. The increased fat tissue and decreased lean muscle in obese individuals can significantly affect how drugs are absorbed into the body and distributed across different tissues. This alteration can lead to variances in the effectiveness and safety of medications, necessitating adjustments in dosing or drug selection for obese patients.One notable...
211
01:24Obesity
1.1K
The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in...
1.1K
01:21Drug Dosing: Obese Patients
189
In the United States, obesity is a prominent concern. It is linked to heightened mortality rates due to increased occurrences of conditions such as hypertension, atherosclerosis, coronary artery disease, and diabetes compared to nonobese individuals. A patient is classified as obese if their actual body weight surpasses the ideal or desirable body weight by 20%, based on Metropolitan Life Insurance Company data. Ideal body weights consider average weights and heights for males and females...
189
01:20Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion
149
Drug metabolism, a critical process in the liver, involves two primary phases: Phase I reactions and Phase II conjugation. Obesity introduces significant alterations in this metabolic process, primarily due to fatty infiltration of the liver, leading to conditions such as nonalcoholic fatty liver disease (NAFLD). This condition can modify the activities of both Phase I and II enzymes, impacting how drugs are metabolized in obese patients.Phase I metabolism sees variable effects across...
149
01:21Inflammatory Bowel Disease V: Surgical Management
420
Surgical interventions for inflammatory bowel disease (IBD), which includes ulcerative colitis and Crohn's disease, are essential in managing symptoms and addressing complications. The selection of surgical procedures is contingent upon the specific conditions and complications that stem from these illnesses.
Here are some common surgical interventions for IBD:
Here are some common surgical interventions for IBD:
420
01:30Bulimia Nervosa
633
Bulimia nervosa is a complex and severe eating disorder characterized by a cyclical pattern of binge-and-purge eating pattern. It generally involves an episode of binge eating, followed by compensatory behaviors such as vomiting, excessive exercise, laxative use, or fasting, to prevent weight gain. Despite often maintaining a normal weight, individuals with bulimia are intensely preoccupied with their body image and harbor an overwhelming fear of gaining weight. This can contribute to the...
633